Tomasz Grzywa, MD, PhD (@drtomaszgrzywa) 's Twitter Profile
Tomasz Grzywa, MD, PhD

@drtomaszgrzywa

Postdoctoral fellow at @childrensphila @penn interested in cancer immunology and immunotherapy. Physician-Scientist. tomasz-grzywa.bsky.social

ID: 1161179456926605312

linkhttp://tomaszgrzywa.com calendar_today13-08-2019 07:35:30

2,2K Tweet

335 Followers

833 Following

Nature Reviews Drug Discovery (@natrevdrugdisc) 's Twitter Profile Photo

In vivo CAR-T cell therapy nature.com/articles/s4157… rdcu.be/eI7zH This new Review discusses how technological advances that remove the need for ex vivo manipulation and chemotherapeutic conditioning could enable wider application of CAR-T cell therapies

In vivo CAR-T cell therapy
nature.com/articles/s4157…
rdcu.be/eI7zH
This new Review discusses how technological advances that remove the need for ex vivo manipulation and chemotherapeutic conditioning  could enable wider application of CAR-T cell therapies
Yakup Ergün (@dr_yakupergun) 's Twitter Profile Photo

Optimizing CAR T cell therapy for solid tumours: a clinical perspective Why has the success achieved with CAR T-cell therapy in hematologic malignancies not been replicated in solid tumors? A great review👇 nature.com/articles/s4157…

Optimizing CAR T cell therapy for solid tumours: a clinical perspective

Why has the success achieved with CAR T-cell therapy in hematologic malignancies not been replicated in solid tumors?

A great review👇

nature.com/articles/s4157…
The Nobel Prize (@nobelprize) 's Twitter Profile Photo

BREAKING NEWS The 2025 #NobelPrize in Physiology or Medicine has been awarded to Mary E. Brunkow, Fred Ramsdell and Shimon Sakaguchi “for their discoveries concerning peripheral immune tolerance.”

BREAKING NEWS
The 2025 #NobelPrize in Physiology or Medicine has been awarded to Mary E. Brunkow, Fred Ramsdell and Shimon Sakaguchi “for their discoveries concerning peripheral immune tolerance.”
The Nobel Prize (@nobelprize) 's Twitter Profile Photo

Mary Brunkow, Fred Ramsdell and Shimon Sakaguchi have been awarded the 2025 Nobel Prize in Physiology or Medicine for their groundbreaking discoveries concerning peripheral immune tolerance that prevents the immune system from harming the body. The Nobel Prize laureates

Mary Brunkow, Fred Ramsdell and Shimon Sakaguchi have been awarded the 2025 Nobel Prize in Physiology or Medicine for their groundbreaking discoveries concerning peripheral immune tolerance that prevents the immune system from harming the body.

The Nobel Prize laureates
Nature Reviews Drug Discovery (@natrevdrugdisc) 's Twitter Profile Photo

Today's Nobel Prize for Physiology or Medicine relates to research on regulatory T cells nobelprize.org/prizes/medicin… For readers interested in harnessing the biology of regulatory T cells to treat disease, here's a comprehensive review nature.com/articles/s4157… rdcu.be/eJHU8

Today's Nobel Prize for Physiology or Medicine relates to research on regulatory T cells nobelprize.org/prizes/medicin…

For readers interested in harnessing the biology of regulatory T cells to treat disease, here's a comprehensive review nature.com/articles/s4157…
rdcu.be/eJHU8
Fabiana Perna (@fabianaperna) 's Twitter Profile Photo

Happy to share my lab’s work out today in Cancer Cell demonstrating that multiple myeloma relapses after CAR T therapy frequently express low BCMA levels. We develop novel SEMA4A-directed CAR T cells eradicating MM, especially under BCMA low conditions. authors.elsevier.com/a/1lvYf_YwcvnX…

Cancer Cell (@cancer_cell) 's Twitter Profile Photo

Online Now: TET2-mutant clonal hematopoiesis enhances macrophage antigen presentation and improves immune checkpoint therapy in solid tumors dlvr.it/TNnYb6

Online Now: TET2-mutant clonal hematopoiesis enhances macrophage antigen presentation and improves immune checkpoint therapy in solid tumors dlvr.it/TNnYb6
Waggoner Lab (@labwaggoner) 's Twitter Profile Photo

Tertiary lymphoid structures in a subset of gliomas that show signs of functional adaptive immune activation and are associated with longer overall patient survival and an immune-permissive tumor microenvironment Immunity Katharina Imkeller 🇩🇪 cell.com/immunity/fullt…

Tertiary lymphoid structures in a subset of gliomas that show signs of functional adaptive immune activation and are associated with longer overall patient survival and an immune-permissive tumor microenvironment <a href="/ImmunityCP/">Immunity</a> <a href="/K_Imkeller/">Katharina Imkeller</a> 🇩🇪
cell.com/immunity/fullt…
Joseph Fraietta (@joefraietta) 's Twitter Profile Photo

Happy to announce publication of our new paper: CCR5-targeted allogeneic gamma–delta CD19 chimeric antigen receptor T cells for HIV-associated B cell-malignancy immunotherapy | Nature Biomedical Engineering Congratulations, Angel and Team!!! nature.com/articles/s4155…

Yan Leyfman, MD (@yleyfman) 's Twitter Profile Photo

💥 Exciting findings from MD Anderson Cancer Center! mRNA vaccines may do more than prevent infections — they could also enhance cancer immunotherapy. A new study found that patients with NSCLC and metastatic melanoma who received a SARS-CoV-2 mRNA vaccine within 100 days of

Tomasz Grzywa, MD, PhD (@drtomaszgrzywa) 's Twitter Profile Photo

SARS-CoV-2 mRNA vaccines sensitize tumours to immune checkpoint blockade - clinically available mRNA vaccines targeting non-tumour-related antigens are potent immune modulators capable of sensitizing tumours to ICIs nature.com/articles/s4158… nature

Tomasz Grzywa, MD, PhD (@drtomaszgrzywa) 's Twitter Profile Photo

Targeting immunosuppressive myeloid cells via implant-mediated slow release of small molecules to prevent glioblastoma recurrence nature.com/articles/s4155… Nature Biomedical Engineering